These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8158885

  • 1. Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.
    Lebovitz HE, Wiegmann TB, Cnaan A, Shahinfar S, Sica DA, Broadstone V, Schwartz SL, Mengel MC, Segal R, Versaggi JA.
    Kidney Int Suppl; 1994 Feb; 45():S150-5. PubMed ID: 8158885
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
    Ciavarella A, Mustacchio A, Silletti A, Franchi R, Levorato M, Campieri C, Borgnino LC, Capozzi G, Morotti L, Vannini P.
    Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
    [Abstract] [Full Text] [Related]

  • 5. Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria.
    Piñol C, Cobos A, Cases A, Esmatges E, Soler J, Closas J, Pascual R, Planas J.
    Kidney Int Suppl; 1996 Jun; 55():S85-7. PubMed ID: 8743519
    [Abstract] [Full Text] [Related]

  • 6. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO, Jeffers BW, Gifford N, Schrier RW.
    Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [Abstract] [Full Text] [Related]

  • 7. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [Abstract] [Full Text] [Related]

  • 8. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 9. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
    Siewert-Delle A, Ljungman S, Hartford M, Wikstrand J.
    Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, Swaminathan R, Nicholls MG, Critchley JA, Cockram CS.
    Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
    [Abstract] [Full Text] [Related]

  • 11. Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
    Chan JC, Nicholls MG, Cheung CK, Law LK, Swaminathan R, Cockram CS.
    Diabetes Care; 1995 Jul; 18(7):1001-6. PubMed ID: 7555530
    [Abstract] [Full Text] [Related]

  • 12. [Urinary albumin excretion in non-insulin-dependent diabetic patients. Effects of an angiotensin-converting enzyme inhibitor].
    Durruty P, Tapia JC, Ugarte C, Pérez E, Krause P, Soto N, García de los Ríos M.
    Rev Med Chil; 1996 Sep; 124(9):1036-44. PubMed ID: 9197016
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH.
    J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
    [Abstract] [Full Text] [Related]

  • 15. Renal function changes in hypertensive patients with non-insulin- dependent diabetes mellitus.
    Rius F, Pizarro E, Castells I, Salinas I, Sanmartí A, Romero R.
    Kidney Int Suppl; 1996 Jun; 55():S88-90. PubMed ID: 8743520
    [Abstract] [Full Text] [Related]

  • 16. Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study.
    Fernández R, Puig JG, Rodríguez-Pérez JC, Garrido J, Redon J, TRAVEND Study Group.
    J Hum Hypertens; 2001 Dec; 15(12):849-56. PubMed ID: 11773987
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Late outcome of a controlled trial of enalapril treatment in progressive chronic renal failure. Hard end-points and influence of proteinuria.
    Kamper AL, Strandgaard S, Leyssac PP.
    Nephrol Dial Transplant; 1995 Dec; 10(7):1182-8. PubMed ID: 7478121
    [Abstract] [Full Text] [Related]

  • 19. Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension.
    Berrut G, Bouhanick B, Fabbri P, Guilloteau G, Bled F, Le Jeune JJ, Fressinaud P, Marre M.
    Clin Nephrol; 1997 Aug; 48(2):92-7. PubMed ID: 9285145
    [Abstract] [Full Text] [Related]

  • 20. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
    van Essen GG, Apperloo AJ, Rensma PL, Stegeman CA, Sluiter WJ, de Zeeuw D, de Jong PE.
    Kidney Int Suppl; 1997 Dec; 63():S58-62. PubMed ID: 9407423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.